胞磷胆碱钠联合尤瑞克林治疗急性脑梗死的疗效观察

目的 探讨胞磷胆碱钠联合尤瑞克林治疗急性脑梗死(ACI)的临床疗效.方法 回顾性分析2019年3月至2020年4月我院收治的78例ACI患者的临床资料,根据治疗方法的不同分为两组各39例.在常规治疗基础上,对照组采用尤瑞克林治疗,观察组采用胞磷胆碱钠联合尤瑞克林治疗,比较两组治疗前后的炎性因子及神经功能.结果 治疗3周...

Observation on the Efficacy of Citicoline Sodium Combined with Urinary Kallidinogenase in the Treatment of Acute Cerebral Infarction

Objective To explore the clinical efficacy of citicoline sodium combined with urinary kallidinogenase in the treatment of acute cerebral infarction(ACI).Methods The clinical data of 78 patients with ACI admitted to our hospital from March 2019 to April 2020 were retrospectively analyzed.All cases were divided into two groups according to different treatment methods,with 39 cases in each group.On the basis of conventional treatment,the control group was treated with urinary kallidinogenase,and the observation group was treated with citicoline sodium combined with urinary kallidinogenase.The inflammatory factors and neurological function before and after treatment were compared between two groups.Results After 3 weeks of treatment,the levels of serum TNF-α,IL-6 and the NIHSS score in both groups were lower than those before treatment,and all indicators of observation group were significantly lower than those of control group(P<0.05).Conclusions Citicoline sodium combined with urinary kallidinogenase in the treatment of ACI can effectively reduce the levels of inflammatory factors and promote the recovery of neurological function of patients.